Form 4: J&J Director Hewson Reports Delayed, New DSU Acquisitions

Johnson & Johnson Director Marillyn A. Hewson filed a Form 4 reporting both a previously unreported acquisition of Deferred Share Units from 2025 and a new acquisition from 2026.

Summary

• Marillyn A. Hewson, a Director at Johnson & Johnson (JNJ), reported the acquisition of Deferred Share Units (DSUs).
• On March 4, 2025, 75.256 DSUs were acquired at a price of $166.1 per DSU, which were not previously reported.
• On March 10, 2026, an additional 206.492 DSUs were acquired at a price of $242.14 per DSU.
• These DSUs represent the deferral of cash retainer under the Issuer's Amended and Restated Deferred Fee Plan for Directors.
• DSUs are to be settled in cash upon termination of the Reporting Person's Directorship, with each DSU representing the fair market value of one share of Common Stock on the business day prior to settlement.
• Following these transactions, Marillyn A. Hewson beneficially owns 14,512.94 DSUs.
• The reported DSU holdings include dividend equivalent rights accrued in connection with Johnson & Johnson's quarterly dividends.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this filing as moderately positive due to the director's increased beneficial ownership, which aligns interests. However, the delayed reporting of a prior transaction introduces a minor compliance concern.

Positives

• The acquisition of additional Deferred Share Units by a director indicates continued alignment of management's interests with those of shareholders.
• The increase in beneficial ownership, even through deferred compensation, demonstrates a long-term commitment to the company's performance.

Negatives

• The acquisition of 75.256 DSUs on March 4, 2025, was not previously reported, indicating a delay in compliance with SEC reporting requirements for that specific transaction.

Future Outlook

NA

Industry Context

StockSavvy.ai notes that deferred share unit plans are a common form of executive and director compensation in large, established companies like Johnson & Johnson. These plans aim to align the long-term interests of directors with those of shareholders by tying a portion of their compensation to the company's stock performance, albeit with a cash settlement upon departure.

Stakeholder Impact

• Shareholders: The increased beneficial ownership by a director, even through deferred compensation, generally signals confidence in the company's long-term prospects and aligns the director's financial interests with shareholder value creation.
• Employees: No direct impact mentioned.

Key Dates

Recommendation

This Form 4 reports routine director compensation in the form of Deferred Share Units and a correction for a previously unreported transaction. While the increased beneficial ownership is a positive for alignment, it does not represent a discretionary open market purchase or sale that would significantly alter the fundamental investment thesis for Johnson & Johnson. Therefore, a 'hold' recommendation is appropriate as this filing alone does not warrant a change in investment strategy.

Keywords

JNJ, Johnson & Johnson, Form 4, Insider Transaction, Deferred Share Units, Director Compensation, Beneficial Ownership, Corporate Governance